1
|
Le DN, Johnson HC, Lam YH, Sun C, Cheng L, Belyk KM. Enantio- and Diastereoselective Total Synthesis of Belzutifan Enabled by Rh-Catalyzed Hydrogenation. Org Lett 2024; 26:4059-4064. [PMID: 38709100 DOI: 10.1021/acs.orglett.4c00982] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/07/2024]
Abstract
Herein, we report a nine-step synthesis of belzutifan enabled by a novel Rh-catalyzed asymmetric hydrogenation to install the contiguous fluorinated stereocenters with high enantioselectivity. Moreover, the final ketone reduction in the synthesis proceeds with high diastereoselectivity, leading to the expedient assembly of the stereotriad. In contrast to the original 16-step synthesis, this route avoids a lengthy bromination-oxidation sequence and introduces the sulfone functionality via nucleophilic aromatic substitution, obviating the need for transition metal catalysis.
Collapse
Affiliation(s)
- Diane N Le
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Heather C Johnson
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Yu-Hong Lam
- Modeling and Informatics, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Chunrui Sun
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| | - Lili Cheng
- Chemistry Service Unit, WuXi AppTec (Tianjin), Tianjin 300457, China
| | - Kevin M Belyk
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
| |
Collapse
|
2
|
O'Connell A, Barry A, Burke AJ, Hutton AE, Bell EL, Green AP, O'Reilly E. Biocatalysis: landmark discoveries and applications in chemical synthesis. Chem Soc Rev 2024; 53:2828-2850. [PMID: 38407834 DOI: 10.1039/d3cs00689a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/27/2024]
Abstract
Biocatalysis has become an important tool in chemical synthesis, allowing access to complex molecules with high levels of activity and selectivity and with low environmental impact. Key discoveries in protein engineering, bioinformatics, recombinant technology and DNA sequencing have contributed towards the rapid acceleration of the field. This tutorial review explores enzyme engineering strategies and high-throughput screening approaches that have been applied for the discovery and development of enzymes for synthetic application. Landmark developments in the field are discussed and have been carefully selected to highlight the diverse synthetic applications of enzymes within the pharmaceutical, agricultural, food and chemical industries. The design and development of artificial biocatalytic cascades is also examined. This tutorial review will give readers an insight into the landmark discoveries and milestones that have helped shape and grow this branch of catalysis since the discovery of the first enzyme.
Collapse
Affiliation(s)
- Adam O'Connell
- School of Chemistry, University College Dublin, Belfield, Dublin 4, Ireland.
| | - Amber Barry
- School of Chemistry, University College Dublin, Belfield, Dublin 4, Ireland.
| | - Ashleigh J Burke
- Manchester Institute of Biotechnology, School of Chemistry, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.
| | - Amy E Hutton
- Manchester Institute of Biotechnology, School of Chemistry, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.
| | - Elizabeth L Bell
- Renewable Resources and Enabling Sciences Center, National Renewable Energy Laboratory, Golden, CO 80401, USA
| | - Anthony P Green
- Manchester Institute of Biotechnology, School of Chemistry, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.
| | - Elaine O'Reilly
- School of Chemistry, University College Dublin, Belfield, Dublin 4, Ireland.
| |
Collapse
|
3
|
France SP, Lewis RD, Martinez CA. The Evolving Nature of Biocatalysis in Pharmaceutical Research and Development. JACS AU 2023; 3:715-735. [PMID: 37006753 PMCID: PMC10052283 DOI: 10.1021/jacsau.2c00712] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/31/2022] [Revised: 02/13/2023] [Accepted: 02/13/2023] [Indexed: 06/19/2023]
Abstract
Biocatalysis is a highly valued enabling technology for pharmaceutical research and development as it can unlock synthetic routes to complex chiral motifs with unparalleled selectivity and efficiency. This perspective aims to review recent advances in the pharmaceutical implementation of biocatalysis across early and late-stage development with a focus on the implementation of processes for preparative-scale syntheses.
Collapse
|
4
|
Piperidine Derivatives: Recent Advances in Synthesis and Pharmacological Applications. Int J Mol Sci 2023; 24:ijms24032937. [PMID: 36769260 PMCID: PMC9917539 DOI: 10.3390/ijms24032937] [Citation(s) in RCA: 9] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2022] [Revised: 01/27/2023] [Accepted: 01/29/2023] [Indexed: 02/05/2023] Open
Abstract
Piperidines are among the most important synthetic fragments for designing drugs and play a significant role in the pharmaceutical industry. Their derivatives are present in more than twenty classes of pharmaceuticals, as well as alkaloids. The current review summarizes recent scientific literature on intra- and intermolecular reactions leading to the formation of various piperidine derivatives: substituted piperidines, spiropiperidines, condensed piperidines, and piperidinones. Moreover, the pharmaceutical applications of synthetic and natural piperidines were covered, as well as the latest scientific advances in the discovery and biological evaluation of potential drugs containing piperidine moiety. This review is designed to help both novice researchers taking their first steps in this field and experienced scientists looking for suitable substrates for the synthesis of biologically active piperidines.
Collapse
|
5
|
Yang Q, Zhao Y, Ma D. Cu-Mediated Ullmann-Type Cross-Coupling and Industrial Applications in Route Design, Process Development, and Scale-up of Pharmaceutical and Agrochemical Processes. Org Process Res Dev 2022. [DOI: 10.1021/acs.oprd.2c00050] [Citation(s) in RCA: 13] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Affiliation(s)
- Qiang Yang
- Synthetic Molecule Design and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, United States
| | - Yinsong Zhao
- Department of Chemistry, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China
| | - Dawei Ma
- State Key Laboratory of Bioorganic and Natural Products Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200032, China
| |
Collapse
|
6
|
Yang LC, Deng H, Renata H. Recent Progress and Developments in Chemoenzymatic and Biocatalytic Dynamic Kinetic Resolution. Org Process Res Dev 2022. [DOI: 10.1021/acs.oprd.1c00463] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Affiliation(s)
- Li-Cheng Yang
- Department of Chemistry, The Scripps Research Institute, 130 Scripps Way, Jupiter, Florida 33458, United States
| | - Heping Deng
- Department of Chemistry, The Scripps Research Institute, 130 Scripps Way, Jupiter, Florida 33458, United States
| | - Hans Renata
- Department of Chemistry, The Scripps Research Institute, 130 Scripps Way, Jupiter, Florida 33458, United States
| |
Collapse
|
7
|
Cheng X, Ma L. Enzymatic synthesis of fluorinated compounds. Appl Microbiol Biotechnol 2021; 105:8033-8058. [PMID: 34625820 PMCID: PMC8500828 DOI: 10.1007/s00253-021-11608-0] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2021] [Revised: 09/16/2021] [Accepted: 09/18/2021] [Indexed: 12/31/2022]
Abstract
Fluorinated compounds are widely used in the fields of molecular imaging, pharmaceuticals, and materials. Fluorinated natural products in nature are rare, and the introduction of fluorine atoms into organic compound molecules can give these compounds new functions and make them have better performance. Therefore, the synthesis of fluorides has attracted more and more attention from biologists and chemists. Even so, achieving selective fluorination is still a huge challenge under mild conditions. In this review, the research progress of enzymatic synthesis of fluorinated compounds is summarized since 2015, including cytochrome P450 enzymes, aldolases, fluoroacetyl coenzyme A thioesterases, lipases, transaminases, reductive aminases, purine nucleoside phosphorylases, polyketide synthases, fluoroacetate dehalogenases, tyrosine phenol-lyases, glycosidases, fluorinases, and multienzyme system. Of all enzyme-catalyzed synthesis methods, the direct formation of the C-F bond by fluorinase is the most effective and promising method. The structure and catalytic mechanism of fluorinase are introduced to understand fluorobiochemistry. Furthermore, the distribution, applications, and future development trends of fluorinated compounds are also outlined. Hopefully, this review will help researchers to understand the significance of enzymatic methods for the synthesis of fluorinated compounds and find or create excellent fluoride synthase in future research.Key points• Fluorinated compounds are distributed in plants and microorganisms, and are used in imaging, medicine, materials science.• Enzyme catalysis is essential for the synthesis of fluorinated compounds.• The loop structure of fluorinase is the key to forming the C-F bond.
Collapse
Affiliation(s)
- Xinkuan Cheng
- State Key Laboratory of Food Nutrition and Safety, Key Laboratory of Industrial Microbiology, Ministry of Education, Tianjin Key Laboratory of Industry Microbiology, National and Local United Engineering Laboratory of Metabolic Control Fermentation Technology, College of Biotechnology, Tianjin University of Science & Technology, No. 29, Thirteenth Street, Binhai New District, Tianjin, 300457, China
| | - Long Ma
- State Key Laboratory of Food Nutrition and Safety, Key Laboratory of Industrial Microbiology, Ministry of Education, Tianjin Key Laboratory of Industry Microbiology, National and Local United Engineering Laboratory of Metabolic Control Fermentation Technology, College of Biotechnology, Tianjin University of Science & Technology, No. 29, Thirteenth Street, Binhai New District, Tianjin, 300457, China.
| |
Collapse
|
8
|
Schnell SD, González JA, Sklyaruk J, Linden A, Gademann K. Boron Trifluoride-Mediated Cycloaddition of 3-Bromotetrazine and Silyl Enol Ethers: Synthesis of 3-Bromo-pyridazines. J Org Chem 2021; 86:12008-12023. [PMID: 34342995 DOI: 10.1021/acs.joc.1c01384] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Abstract
Pyridazines are important scaffolds for medicinal chemistry or crop protection agents, yet the selective preparation of 3-bromo-pyridazines with high regiocontrol remains difficult. We achieved the Lewis acid-mediated inverse electron demand Diels-Alder reaction between 3-monosubstituted s-tetrazine and silyl enol ethers and obtained functionalized pyridazines. In the case of 1-monosubstituted silyl enol ethers, exclusive regioselectivity was observed. Downstream functionalization of the resulting 3-bromo-pyridazines was demonstrated utilizing several cross-coupling protocols to synthesize 3,4-disubstituted pyridazines with excellent control over the substitution pattern.
Collapse
Affiliation(s)
- Simon D Schnell
- Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland
| | - Jorge A González
- Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland
| | - Jan Sklyaruk
- Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland
| | - Anthony Linden
- Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland
| | - Karl Gademann
- Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland
| |
Collapse
|
9
|
García‐Ramos M, Cuetos A, Kroutil W, Grogan G, Lavandera I. The Reactivity of α‐Fluoroketones with PLP Dependent Enzymes: Transaminases as Hydrodefluorinases. ChemCatChem 2021. [DOI: 10.1002/cctc.202100901] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Affiliation(s)
- Marina García‐Ramos
- Organic and Inorganic Chemistry Department University of Oviedo Avenida Julián Clavería 8 33006 Oviedo Spain
| | - Aníbal Cuetos
- York Structural Biology Laboratory Department of Chemistry University of York Heslington York YO10 5DD UK
- ENANTIA C/ Baldiri Reixac, 10 08028 Barcelona Spain
| | - Wolfgang Kroutil
- Institute of Chemistry NAWI Graz Field of Excellence BioHealth University of Graz Heinrichstrasse 28 8010 Graz Austria
| | - Gideon Grogan
- York Structural Biology Laboratory Department of Chemistry University of York Heslington York YO10 5DD UK
| | - Iván Lavandera
- Organic and Inorganic Chemistry Department University of Oviedo Avenida Julián Clavería 8 33006 Oviedo Spain
| |
Collapse
|
10
|
Charvillat T, Bernardelli P, Daumas M, Pannecoucke X, Ferey V, Besset T. Hydrogenation of fluorinated molecules: an overview. Chem Soc Rev 2021; 50:8178-8192. [PMID: 34060550 DOI: 10.1039/d0cs00736f] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
The review aims at providing an overview on the developments made in hydrogenation reactions of molecules having various fluorinated groups (F, CF3, CF2H, CF2Rf). Indeed, the hydrogenation of fluorine-containing molecules is a straightforward and atom-economical way to access challenging (chiral) fluorinated scaffolds. This promising field is still in its infancy and milestones are expected in the coming years. To illustrate that, the review will highlight the major contributions made in that field and will be organized by fluorinated groups.
Collapse
Affiliation(s)
- T Charvillat
- Normandie Univ, INSA Rouen, UNIROUEN, CNRS, COBRA (UMR 6014), 76000 Rouen, France.
| | - P Bernardelli
- Sanofi Sanofi R&D, Integrated Drug Discovery, Small Molecule Medicinal Chemistry, 1 avenue Pierre Brossolette, 91385 Chilly-Mazarin, France
| | - M Daumas
- Sanofi R&D, 371 rue du Professeur Blayac, 34184 Montpellier, France
| | - X Pannecoucke
- Normandie Univ, INSA Rouen, UNIROUEN, CNRS, COBRA (UMR 6014), 76000 Rouen, France.
| | - V Ferey
- Sanofi R&D, 371 rue du Professeur Blayac, 34184 Montpellier, France
| | - T Besset
- Normandie Univ, INSA Rouen, UNIROUEN, CNRS, COBRA (UMR 6014), 76000 Rouen, France.
| |
Collapse
|
11
|
García-Vázquez V, Hoteite L, Lakeland CP, Watson DW, Harrity JPA. A Pd-Catalyzed [4 + 2] Annulation Approach to Fluorinated N-Heterocycles. Org Lett 2021; 23:2811-2815. [PMID: 33759534 PMCID: PMC8041373 DOI: 10.1021/acs.orglett.1c00752] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
3-Fluoro- and trifluoromethylthio-piperidines represent important building blocks for discovery chemistry. We report a simple and efficient method to access analogs of these compounds that are armed with rich functionality allowing them to be chemoselectively derivatized with high diastereocontrol.
Collapse
Affiliation(s)
| | - Larry Hoteite
- Department of Chemistry, University of Sheffield, Sheffield, S3 7HF, United Kingdom
| | | | - David W Watson
- Medicinal Chemistry, Oncology R&D Research and Early Development, AstraZeneca Cambridge Science Park, Unit 310 Darwin Building, Cambridge, CB4 0WG, United Kingdom
| | - Joseph P A Harrity
- Department of Chemistry, University of Sheffield, Sheffield, S3 7HF, United Kingdom
| |
Collapse
|
12
|
Efforts towards a Noyori reduction of a 3-fluorpiperidin-4-one with dynamic kinetic resolution. Tetrahedron Lett 2021. [DOI: 10.1016/j.tetlet.2020.152764] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|
13
|
Qu B, Saha A, Li G, Zeng X, Wang X, Haddad N, Hou X, Lorenz JC, Wu L, Pennino S, Lee H, Song JJ, Senanayake CH. Large Scale Practical Synthesis of Enantiomerically Pure cis-4-Amino-3-fluoro-1-methylpiperidine via Rhodium-Catalyzed Asymmetric Hydrogenation of a Tetrasubstituted Fluoroalkene. Org Process Res Dev 2021. [DOI: 10.1021/acs.oprd.0c00525] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Bo Qu
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Anjan Saha
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Guisheng Li
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Xingzhong Zeng
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Xiaojun Wang
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Nizar Haddad
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Xiaowen Hou
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Jon C. Lorenz
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Lifen Wu
- Material and Analytical Sciences, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Scott Pennino
- Material and Analytical Sciences, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Heewon Lee
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Jinhua J. Song
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| | - Chris H. Senanayake
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States
| |
Collapse
|
14
|
Biosca M, Diéguez M, Zanotti-Gerosa A. Asymmetric hydrogenation in industry. ADVANCES IN CATALYSIS 2021. [DOI: 10.1016/bs.acat.2021.08.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
15
|
|
16
|
Bai D, Li L, Li X, Lu Y, Wu Y, Rajendra Prasad Reddy B, Ning Y. Fluorocyclization of Vinyl Azides for the Formation of 3‐Azido Heterocycles. Chem Asian J 2020; 15:4038-4042. [DOI: 10.1002/asia.202001175] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2020] [Revised: 10/22/2020] [Indexed: 12/12/2022]
Affiliation(s)
- Diangang Bai
- School of Chemistry and School of Chemistry and Life Science Anshan Normal University Anshan 114005 P. R. China
| | - Linxuan Li
- Department of Chemistry Northeast Normal University Changchun 130024 P. R. China
| | - Xiaomeng Li
- Department of Chemistry Northeast Normal University Changchun 130024 P. R. China
| | - Ying Lu
- Department of Chemistry Northeast Normal University Changchun 130024 P. R. China
| | - Yong Wu
- Department of Chemistry Northeast Normal University Changchun 130024 P. R. China
| | | | - Yongquan Ning
- School of Chemistry and School of Chemistry and Life Science Anshan Normal University Anshan 114005 P. R. China
- Department of Chemistry Northeast Normal University Changchun 130024 P. R. China
| |
Collapse
|
17
|
Phansavath P, Ratovelomanana-Vidal V, Ponra S, Boudet B. Recent Developments in Transition-Metal-Catalyzed Asymmetric Hydrogenation of Enamides. SYNTHESIS-STUTTGART 2020. [DOI: 10.1055/s-0040-1705939] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
AbstractThe catalytic asymmetric hydrogenation of prochiral olefins is one of the most widely studied and utilized transformations in asymmetric synthesis. This straightforward, atom economical, inherently direct and sustainable strategy induces chirality in a broad range of substrates and is widely relevant for both industrial applications and academic research. In addition, the asymmetric hydrogenation of enamides has been widely used for the synthesis of chiral amines and their derivatives. In this review, we summarize the recent work in this field, focusing on the development of new catalytic systems and on the extension of these asymmetric reductions to new classes of enamides.1 Introduction2 Asymmetric Hydrogenation of Trisubstituted Enamides2.1 Ruthenium Catalysts2.2 Rhodium Catalysts2.3 Iridium Catalysts2.4 Nickel Catalysts2.5 Cobalt Catalysts3 Asymmetric Hydrogenation of Tetrasubstituted Enamides3.1 Ruthenium Catalysts3.2 Rhodium Catalysts3.3 Nickel Catalysts4 Asymmetric Hydrogenation of Terminal Enamides4.1 Rhodium Catalysts4.2 Cobalt Catalysts5 Rhodium-Catalyzed Asymmetric Hydrogenation of Miscellaneous Enamides6 Conclusions
Collapse
Affiliation(s)
- Phannarath Phansavath
- PSL University, Chimie ParisTech-CNRS, Institute of Chemistry for Life & Health Sciences, CSB2D Team
| | | | - Sudipta Ponra
- PSL University, Chimie ParisTech-CNRS, Institute of Chemistry for Life & Health Sciences, CSB2D Team
| | | |
Collapse
|
18
|
Benson H, Bones K, Churchill G, Ford G, Frodsham L, Janbon S, Millington F, Powell L, Raw SA, Reid J, Stark A, Steven A. Development of the Convergent, Kilogram-Scale Synthesis of an Antibacterial Clinical Candidate Using Enantioselective Hydrogenation. Org Process Res Dev 2020. [DOI: 10.1021/acs.oprd.0c00029] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Affiliation(s)
- Helen Benson
- Early Chemical Development, Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield SK10 2NA, U.K
| | - Karen Bones
- Pharmaceutical Technology & Development, AstraZeneca Macclesfield Campus, Charter Way, Macclesfield SK10 2NA, U.K
| | - Gwydion Churchill
- Pharmaceutical Technology & Development, AstraZeneca Macclesfield Campus, Charter Way, Macclesfield SK10 2NA, U.K
| | - Gair Ford
- Pharmaceutical Technology & Development, AstraZeneca Macclesfield Campus, Charter Way, Macclesfield SK10 2NA, U.K
| | - Lianne Frodsham
- Pharmaceutical Technology & Development, AstraZeneca Macclesfield Campus, Charter Way, Macclesfield SK10 2NA, U.K
| | - Sophie Janbon
- Early Chemical Development, Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield SK10 2NA, U.K
| | - Fiona Millington
- Pharmaceutical Technology & Development, AstraZeneca Macclesfield Campus, Charter Way, Macclesfield SK10 2NA, U.K
| | - Lyn Powell
- Pharmaceutical Technology & Development, AstraZeneca Macclesfield Campus, Charter Way, Macclesfield SK10 2NA, U.K
| | - Steven A. Raw
- Pharmaceutical Technology & Development, AstraZeneca Macclesfield Campus, Charter Way, Macclesfield SK10 2NA, U.K
| | - Julie Reid
- Pharmaceutical Technology & Development, AstraZeneca Macclesfield Campus, Charter Way, Macclesfield SK10 2NA, U.K
| | - Andrew Stark
- Early Chemical Development, Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield SK10 2NA, U.K
| | - Alan Steven
- Pharmaceutical Technology & Development, AstraZeneca Macclesfield Campus, Charter Way, Macclesfield SK10 2NA, U.K
| |
Collapse
|
19
|
Dubowchik GM, Conway CM, Xin AW. Blocking the CGRP Pathway for Acute and Preventive Treatment of Migraine: The Evolution of Success. J Med Chem 2020; 63:6600-6623. [PMID: 32058712 DOI: 10.1021/acs.jmedchem.9b01810] [Citation(s) in RCA: 34] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
The pivotal role of calcitonin gene-related peptide (CGRP) in migraine pathophysiology was identified over 30 years ago, but the successful clinical development of targeted therapies has only recently been realized. This Perspective traces the decades long evolution of medicinal chemistry required to advance small molecule CGRP receptor antagonists, also called gepants, including the current clinical agents rimegepant, vazegepant, ubrogepant, and atogepant. Providing clinically effective blockade of CGRP signaling required surmounting multiple challenging hurdles, including defeating a sizable ligand with subnanomolar affinity for its receptor, designing antagonists with an extended confirmation and multiple pharmacophores while retaining solubility and oral bioavailability, and achieving circulating free plasma levels that provided near maximal CGRP receptor coverage. The clinical efficacy of oral and intranasal gepants and the injectable CGRP monoclonal antibodies (mAbs) are described, as are recent synthetic developments that have benefited from new structural biology data. The first oral gepant was recently approved and heralds a new era in the treatment of migraine.
Collapse
Affiliation(s)
- Gene M Dubowchik
- Biohaven Pharmaceuticals Inc., 215 Church Street, New Haven, Connecticut 06510, United States
| | - Charles M Conway
- Biohaven Pharmaceuticals Inc., 215 Church Street, New Haven, Connecticut 06510, United States
| | - Alison W Xin
- Biohaven Pharmaceuticals Inc., 215 Church Street, New Haven, Connecticut 06510, United States
| |
Collapse
|
20
|
Zhong H, Shevlin M, Chirik PJ. Cobalt-Catalyzed Asymmetric Hydrogenation of α,β-Unsaturated Carboxylic Acids by Homolytic H2 Cleavage. J Am Chem Soc 2020; 142:5272-5281. [DOI: 10.1021/jacs.9b13876] [Citation(s) in RCA: 54] [Impact Index Per Article: 13.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Affiliation(s)
- Hongyu Zhong
- Department of Chemistry, Princeton University, Princeton, New Jersey 08544, United States
| | - Michael Shevlin
- Department of Process Research & Development, Merck & Company, Limited, Rahway, New Jersey 07065, United States
| | - Paul J. Chirik
- Department of Chemistry, Princeton University, Princeton, New Jersey 08544, United States
| |
Collapse
|